Mental health status of the European population and its determinants: A cross-national comparison study.

IF 6.7 2区医学 Q1 PSYCHIATRY

European Psychiatry Pub Date : 2025-04-24 DOI:10.1192/j.eurpsy.2025.2449

Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, Celso Arango

{"title":"Mental health status of the European population and its determinants: A cross-national comparison study.","authors":"Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, Celso Arango","doi":"10.1192/j.eurpsy.2025.2449","DOIUrl":null,"url":null,"abstract":"Background: This study aimed to provide an up-to-date cross-national comparison of the European population mental health (MH) status and its determinants.Methods: For the European Union (EU) 27 countries and the UK 6 Key Performance Indicators (KPIs) in MH status (e.g., prevalence of mental disorders) and 19 KPIs in individual (e.g., smoking), environmental (e.g., air pollution) and socioeconomic (e.g., poor housing conditions) determinants of MH were measured. KPIs scores were standardised in a 1-10 Likert Scale (1: worst performance; 10: best performance), thus allowing between-country comparisons of the relative performance. Exploratory unadjusted bivariate correlations between KPIs-transformed scores were run.Results: Based on the KPIs-transformed scores, Slovakia (8.3), Cyprus (7.8), and Greece (7.1) had the best MH status, while Sweden (3.1), UK (2.6), and The Netherlands (2.1) had the poorest MH status. Regarding determinants of MH Finland (8.0), Sweden, and Estonia (7.5) had the lowest MH risk, while France (3.1) and Romania (2.8) had the highest risk.Smoking (r = -0.43, p = .021), alcohol use (r = 0.57, p = .002), daylight hours (r = 0.74, p < .001), ecoanxiety (r = -0.51, p = .005), air pollution (r = -0.46, p = .015), commuting time (r = 0.42, p = .026), and Fragile State Index (r = -0.44, p = .018) correlated with overall MH status.Conclusions: Population-level MH status and its determinants varied across European countries, including \"low-risk, poor MH status\" and \"high-risk, good MH status\" countries. Further non-tested determinants of MH and/or between-country differences in responsiveness to MH needs may explain this discrepancy. These results should guide future evidence-based public MH policymaking and universal preventive strategies in Europe.","PeriodicalId":12155,"journal":{"name":"European Psychiatry","volume":" ","pages":"e103"},"PeriodicalIF":6.7000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344470/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1192/j.eurpsy.2025.2449","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This study aimed to provide an up-to-date cross-national comparison of the European population mental health (MH) status and its determinants.

Methods: For the European Union (EU) 27 countries and the UK 6 Key Performance Indicators (KPIs) in MH status (e.g., prevalence of mental disorders) and 19 KPIs in individual (e.g., smoking), environmental (e.g., air pollution) and socioeconomic (e.g., poor housing conditions) determinants of MH were measured. KPIs scores were standardised in a 1-10 Likert Scale (1: worst performance; 10: best performance), thus allowing between-country comparisons of the relative performance. Exploratory unadjusted bivariate correlations between KPIs-transformed scores were run.

Results: Based on the KPIs-transformed scores, Slovakia (8.3), Cyprus (7.8), and Greece (7.1) had the best MH status, while Sweden (3.1), UK (2.6), and The Netherlands (2.1) had the poorest MH status. Regarding determinants of MH Finland (8.0), Sweden, and Estonia (7.5) had the lowest MH risk, while France (3.1) and Romania (2.8) had the highest risk.Smoking (r = -0.43, p = .021), alcohol use (r = 0.57, p = .002), daylight hours (r = 0.74, p < .001), ecoanxiety (r = -0.51, p = .005), air pollution (r = -0.46, p = .015), commuting time (r = 0.42, p = .026), and Fragile State Index (r = -0.44, p = .018) correlated with overall MH status.

Conclusions: Population-level MH status and its determinants varied across European countries, including "low-risk, poor MH status" and "high-risk, good MH status" countries. Further non-tested determinants of MH and/or between-country differences in responsiveness to MH needs may explain this discrepancy. These results should guide future evidence-based public MH policymaking and universal preventive strategies in Europe.

Abstract Image

查看原文本刊更多论文

欧洲人口的心理健康状况及其决定因素：一项跨国比较研究。

背景：本研究旨在提供欧洲人口心理健康（MH）状况及其决定因素的最新跨国比较。方法：针对欧盟（EU） 27个国家和英国，测量了MH状况的6个关键绩效指标（kpi）（如精神障碍患病率）和个人（如吸烟）、环境（如空气污染）和社会经济（如住房条件差）决定因素的19个kpi。kpi得分采用1-10李克特量表进行标准化(1：最差表现；10：最佳表现)，从而可以比较国家间的相对表现。在kpi转换得分之间进行探索性的未调整双变量相关性分析。结果：根据kpi转换得分，斯洛伐克（8.3）、塞浦路斯（7.8）和希腊（7.1）的MH状况最好，而瑞典（3.1）、英国（2.6）和荷兰（2.1）的MH状况最差。关于MH的决定因素，芬兰（8.0）、瑞典和爱沙尼亚（7.5）的MH风险最低，而法国（3.1）和罗马尼亚（2.8）的风险最高。吸烟(r = -0.43, p = .021),饮酒(r = 0.57, p = .002),白天(r = 0.74, p r = -0.51, p = .005),空气污染(r = -0.46, p = .015),通勤时间(r = 0.42, p = .026)和脆弱状态指数(r = -0.44, p = .018)与整体MH状态。结论：人群层面的MH状况及其决定因素在欧洲各国各不相同，包括“低风险，MH状况差”和“高风险，MH状况好”的国家。进一步的未经测试的MH决定因素和/或国家之间对MH需求反应的差异可以解释这种差异。这些结果应指导欧洲未来基于证据的公共卫生保健决策和普遍预防战略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Psychiatry 医学-精神病学

CiteScore

8.50

自引率

3.80%

发文量

2338

审稿时长

4.5 weeks

期刊介绍： European Psychiatry, the official journal of the European Psychiatric Association, is dedicated to sharing cutting-edge research, policy updates, and fostering dialogue among clinicians, researchers, and patient advocates in the fields of psychiatry, mental health, behavioral science, and neuroscience. This peer-reviewed, Open Access journal strives to publish the latest advancements across various mental health issues, including diagnostic and treatment breakthroughs, as well as advancements in understanding the biological foundations of mental, behavioral, and cognitive functions in both clinical and general population studies.